Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Rxsight Inc
(NQ:
RXST
)
56.45
+2.12 (+3.90%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Rxsight Inc
< Previous
1
2
3
4
Next >
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
February 29, 2024
From
RxSight, Inc.
Via
GlobeNewswire
Forecasting The Future: 9 Analyst Projections For RxSight
February 29, 2024
Via
Benzinga
Recap: RxSight Q4 Earnings
February 28, 2024
Via
Benzinga
RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
February 28, 2024
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
February 14, 2024
From
RxSight, Inc.
Via
GlobeNewswire
Stifel Maintains Buy Rating for RxSight: Here's What You Need To Know
February 12, 2024
Via
Benzinga
The Analyst Landscape: 8 Takes On RxSight
January 29, 2024
Via
Benzinga
Earnings Scheduled For February 28, 2024
February 28, 2024
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion.
Via
Benzinga
RxSight's Earnings Outlook
February 27, 2024
Via
Benzinga
Breaking Down RxSight: 5 Analysts Share Their Views
January 08, 2024
Via
Benzinga
Analyst Expectations for RxSight's Future
December 13, 2023
Via
Benzinga
RxSight: Q3 Earnings Insights
November 09, 2023
Via
Benzinga
Insiders are selling these hot stocks on track for higher prices
February 07, 2024
Insiders are selling these hot stocks and may cap gains in the near term, but long-term gains are in the outlook. Analysts support them and raise their targets.
Via
MarketBeat
Jim Cramer: This Healthcare Stock Is 'Too Risky,' But Shares Jumped 64% Over Past Month
January 25, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is "too risky."
Via
Benzinga
3 Stocks to Buy BEFORE They Become Household Names
January 12, 2024
The best way to find 100 baggers is to invest in undiscovered stock gems that have yet to become household names.
Via
InvestorPlace
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance
January 07, 2024
From
RxSight, Inc.
Via
GlobeNewswire
Where RxSight Stands With Analysts
August 08, 2023
Via
Benzinga
RxSight's Earnings: A Preview
August 04, 2023
Via
Benzinga
The Latest Analyst Ratings for RxSight
July 12, 2023
Via
Benzinga
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 08, 2024
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...
Via
Benzinga
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
December 27, 2023
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. Reports Third Quarter 2023 Financial Results
November 09, 2023
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. Educational and Product Announcements for AAO 2023
November 02, 2023
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Report Third Quarter Financial Results on November 9, 2023
October 26, 2023
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Present at the Wells Fargo Healthcare Conference
August 23, 2023
From
RxSight, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 08, 2023
Via
Benzinga
RxSight, Inc. Reports Second Quarter 2023 Financial Results
August 07, 2023
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Report Second Quarter Financial Results on August 7, 2023
July 25, 2023
From
RxSight, Inc.
Via
GlobeNewswire
RxSight Is A Potential Acquisition Target: Analyst Highlights How LAL Revenue Mix Could Drive Share Price To $45+
July 12, 2023
Needham analyst David Saxon reiterated a Buy rating on RxSight, Inc. (NASDAQ: RXST),
Via
Benzinga
RxSight, Inc. Reports First Quarter 2023 Financial Results
May 09, 2023
From
RxSight, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.